Epoetin Injection

Epoetin 2000 IU/.5 ml Injection সম্পর্কে

Epoetin 2000 IU/.5 ml Injection একটি ইনজেকশন ঔষধ, যার জেনেরিক নাম Erythropoietin এবং শক্তি ২০০০ IU/.৫ ml। Epoetin-এর সাথে Erythropoietin-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই ব্র্যান্ডের প্রস্তুতকারক Incepta Pharmaceuticals Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Erythropoietin-এর ৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।

Epoetin 2000 IU/.5 ml Injection কী?

Made by Incepta Pharmaceuticals Ltd., Epoetin is a injection whose active ingredient is Erythropoietin. It belongs to a group of medicines used for anemia linked to long-term kidney failure and for anemia in some cancer patients receiving chemotherapy. The doctor decides the dose and course.

Epoetin-এর ব্যবহার

It is also used for anaemia in some patients with non-myeloid cancers where the anaemia is caused by chemotherapy given alongside. Epoetin is used to treat anemia linked to chronic kidney failure, including in people who are on dialysis and those who are not. It is not a general tonic for tiredness. Ask your doctor whether it is right for your condition.

Epoetin কীভাবে ব্যবহার করবেন

The doctor sets the dose and schedule and adjusts them based on blood test results. Epoetin is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Do not take more than prescribed. Complete the course exactly as prescribed. The dose and how often it is given are decided by the doctor, based on blood tests and your condition.

Epoetin-এর পার্শ্বপ্রতিক্রিয়া

Raised blood pressure is the most common side effect, and palpitations can occur. Some people may have nausea, vomiting, loss of appetite or diarrhea. Palpitations and raised potassium levels can occur, and allergic reactions are possible. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

সতর্কতা ও নিরাপত্তা

Always tell your doctor about other medicines and health conditions. In pregnancy it is used only when clearly needed; it is not known whether it passes into breast milk, so breastfeeding mothers should ask the doctor first.

সাধারণ প্রশ্ন

Why is Epoetin prescribed?

It is also used for anaemia in some patients with non-myeloid cancers where the anaemia is caused by chemotherapy given alongside. Epoetin is used to treat anemia linked to chronic kidney failure, including in people who are on dialysis and those who are not.

How do I use Epoetin correctly?

The doctor sets the dose and schedule and adjusts them based on blood test results. Epoetin is given as an injection by a healthcare professional.

Can Epoetin cause side effects?

Raised blood pressure is the most common side effect, and palpitations can occur. Some people may have nausea, vomiting, loss of appetite or diarrhea.

Can I use Epoetin in pregnancy or while breastfeeding?

Always tell your doctor about other medicines and health conditions. In pregnancy it is used only when clearly needed; it is not known whether it passes into breast milk, so breastfeeding mothers should ask the doctor first.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • ... Read more
Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
  • Anemia related to therapy with zidovudine in HIV-infected patients.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Treatment of anemia in chronic renal failure: Erythropoietin is administered to maintain hemoglobin concentration between 11 to 12 g/dl and hematocrit of 33-36 % in adults.

Starting dose:
  • Adult: Usually 50 to 100 lU/kg three times in a week (TIW) by IV or Subcutaneous route.
  • Pediatric: 50 lU/kg TIW by IV or Subcutaneous route.
Dose adjustment: Dose should be increased if hematocrit doses not increase by 5 to 6 points after 8 weeks therapy, and hematocrit is below suggested target range. Dose should be reduced when hematocrit approaches 36% or hematocrit increases >4 points in any 2-week period.

Maintenance dose: Maintenance dose must be individualized for each patient. In patients undergoing dialysis, the median maintenance dose is 75 lU/kg TIW, with a range from 12.5 to 525 lU/kg TIW as directed by the physician. In CRF patients not on dialysis, maintenance dose is 75 to 150 lU/kg/week.

Treatment of Anemia in Cancer Patients on Chemotherapy:

Starting dose:
  • Adult: 150 lU/kg TIW by Subcutaneous route or 40,000 IU Subcutaneous route weekly.
  • Pediatric: 25 to 300 lU/kg 3 to 7 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased to 300 lU/kg TIW. If the hematocrit exceeds 40%, the dose should be withheld until the hematocrit falls to 36%.The dose should be reduced to 25% when treatment is resumed and titrated to maintain the desired hematocrit.

Surgery Patients: The recommended dose is 300 lU/kg/day subcutaneously for 10 days before surgery, on the day of surgery, and for 4 days after surgery. An alternate dose schedule is 600 lU/kg subcutaneously in once weekly dose (21, 14, and 7 days before surgery) plus a fourth dose on the day of surgery.

Zidovudine-treated HIV-infected Patients:
Starting dose
  • Adult: 100 lU/kg as an IV or Subcutaneous injection TIW for 8 weeks.
  • Pediatric: 50 to 400 lU/kg 2 to 3 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased by 50-1001U/kg TIW. Response should be evaluated every 4 to 8 weeks thereafter and the dose adjusted accordingly by 50 to 100 lU/kg increments TIW.

Maintenance dose: The dose is titrated to maintain the hematocrit between 33-36%.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Erythropoietin is contraindicated in patients with:
  • Uncontrolled hypertension
  • Known hypersensitivity to mammalian cell-derived products
  • A history of hypersensitivity to Erythropoietin or any component of the preparation.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

General: Headache, dizziness, fever, malaise, arthralgia and occasionally hyperkalemia. Cardiovascular: Hypertension is the most common side effect, palpitations. Gastrointestinal: Nausea, vomiting, anorexia and diarrhea may occur occasionally. Allergic reactions.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category C. Since there are no controlled studies of erythropoietin in pregnant women, and because animal reproduction studies are not always predictive of human responses, erythropoietin should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when erythropoietin is administered to a nursing woman.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Erythropoietin should be used with caution in those patients with controlled hypertension, ischaemic vascular disease, history of seizures, or suspected allergy to the product.

Iron evaluation: Prior to and during Erythropoietin therapy, the patient's iron stores, including transferrin saturation and serum ferritin, should be evaluated. Transferrin saturation should be at least 20%, and ferritin should be at least 100 ng/ml. Virtually all patients will require supplemental Iron to increase or maintain transferrin saturation to levels that will adequately support erythropoiesis.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Doses of up to 1500 lU/kg TIW for 3 to 4 weeks have been administered to adults without any direct toxic effects. If the suggested target range is exceeded, drug therapy may be temporarily withheld until the hemoglobin returns to the suggested target range. If polycythemia is of concern, phlebotomy may be indicated to decrease the hemoglobin.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Erythropoietin should be stored at 2°C to 8°C. Protect from light. Do not freeze & avoid shaking.

বিকল্প ব্র্যান্ড: Erythropoietin

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Epoetin Injection

10000 IU/ml

Erythropoietin

Incepta Pharmaceuticals Ltd.

দাম দেওয়া নেই

Epoetin Injection

3000 IU/.75 ml

Erythropoietin

Incepta Pharmaceuticals Ltd.

দাম দেওয়া নেই

Epoetin Injection

5000 IU/.5 ml

Erythropoietin

Incepta Pharmaceuticals Ltd.

দাম দেওয়া নেই

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।